Skip to content
etfnews.live

Company

Glaxosmithkline Pharmaceuticals

India

The ETFs we cover that hold this company, and its latest news.

Which ETFs hold Glaxosmithkline Pharmaceuticals?

Held by 36 covered funds. Sorted by Glaxosmithkline Pharmaceuticals’ share of each fund. Holdings as of each fund’s latest SEC filing.

FundShare of fund
SMINiShares MSCI India Small-Cap0.3%
EMGFiShares Emerging Markets Equity Factor0.1%
FLINFranklin FTSE India0.1%
EEMSiShares MSCI Emerging Markets Small-Cap0.1%
EPIWisdomTree India Earnings Fund0.0%
INDXtrackers Nifty 500 India0.0%
XCWisdomTree True Emerging Markets Fund0.0%
XCNYSPDR S&P Emerging Markets ex-China0.0%
DEHPDimensional Emerging Markets High Profitability0.0%
EMCRXtrackers Emerging Markets Carbon Reduction and Climate Improvers0.0%
DFSEDimensional Emerging Markets Sustainability Core 10.0%
GLOFiShares Global Equity Factor0.0%
GSEEGoldman Sachs MarketBeta Emerging Markets Equity0.0%
DEXCDimensional Emerging Markets ex China Core Equity0.0%
SCHESchwab Emerging Markets Equity0.0%
VEXCVanguard Emerging Markets Ex-China0.0%
AVXCAvantis Emerging Markets ex-China Equity0.0%
BKEMBNY Mellon Emerging Markets Equity0.0%
FLAXFranklin FTSE Asia ex Japan0.0%
JHEMJohn Hancock Multifactor Emerging Markets0.0%
VWOVanguard Emerging Markets Stock Index Fund0.0%
AVSEAvantis Responsible Emerging Markets Equity0.0%
DFAEDimensional Emerging Core Equity Market0.0%
DFEMDimensional Emerging Markets Core Equity 20.0%
IEMGiShares Core MSCI Emerging Markets0.0%
AVENXAvantis Emerging Markets Equity Fund0.0%
AVEMAvantis Emerging Markets Equity0.0%
IXUSiShares Core MSCI Total International Stock0.0%
GXUSGoldman Sachs MarketBeta Total International Equity0.0%
DFAXDimensional World ex U.S. Core Equity 20.0%
SSGVXState Street Global All Cap Equity ex-U.S. Index Portfolio0.0%
TLTEFlexShares Morningstar Emerging Markets Factor Tilt Index Fund0.0%
VEUVanguard FTSE All-World Ex-US Index Fund0.0%
VXUSVanguard Total International Stock Index Fund0.0%
VSGXVanguard ESG International Stock0.0%
VTVanguard Total World Stock Index Fund0.0%

Where to buy these ETFs

[Affiliate and risk wording from the law firm]

Latest Glaxosmithkline Pharmaceuticals news

No recent stories about Glaxosmithkline Pharmaceuticals.